Associations of polyunsaturated fatty acids with residual depression or anxiety in older people with major depression

Journal of Affective Disorders

Volumn 136, Issue 3, 2012, Pages 918-925

  Jadoon, Ayesha ^a   Chiu, Chih Chiang ^b,c,d   McDermott, Lindsay ^a   Cunningham, Phil ^c   Frangou, Sophia ^c   Chang, Ching Jui ^e   Sun, I Wen ^f   Liu, Shen Ing ^f   Lu, Mong Liang ^d,g   Su, Kuan Pin ^h,i   Huang, Shih Yi ⁱ   Stewart, Robert ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e CATHAY GENERAL HOSPITAL   (Taiwan)

^f MACKAY MEMORIAL HOSPITAL   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^h CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

ⁱ TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Anxiety; Late life depression; Omega 3 fatty acids; Polyunsaturated fatty acids; Residual depression

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; INSULIN; LINOLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; ORAL ANTIDIABETIC AGENT; POLYUNSATURATED FATTY ACID;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ANXIETY DISORDER; ARTICLE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ERYTHROCYTE MEMBRANE; FATTY ACID BLOOD LEVEL; FEMALE; GAS CHROMATOGRAPHY; HAMILTON SCALE; HUMAN; HYPERTENSION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PLASMA; PRIORITY JOURNAL; REMISSION; RESIDUAL DEPRESSION;

AGED; AGED, 80 AND OVER; ANXIETY; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; ERYTHROCYTE MEMBRANE; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; LINOLEIC ACID; MALE; MIDDLE AGED;

EID: 84857358938     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.09.007     Document Type: Article

References (58)

1. O. Adam, A. Tesche, and G. Wolfram Impact of linoleic acid intake on arachidonic acid formation and eicosanoid biosynthesis in humans Prostaglandins, Leukotrienes, and Essential Fatty Acids 79 2008 177 181
2. P.B. Adams, S. Lawson, A. Sanigorski, and A.J. Sinclair Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression Lipids 31 1996 S157 S161 (Suppl)
3. G.S. Alexopoulos Depression in the elderly Lancet 365 2005 1961 1970
4. K.M. Appleton, P.J. Rogers, and A.R. Ness Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood American Journal of Clinical Nutrition 91 2009 757 770
5. J.A. Balint, E.C. Kyriakides, and D.A. Beeler Fatty acid desaturation in lung: inhibition by unsaturated fatty acids Journal of Lipid Research 21 1980 868 873
6. R.P. Bazinet Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder? Biochemical Society Transactions 37 2009 1104 1109
7. D.G. Blazer Depression in late life: review and commentary The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 58 2003 249 265
8. M.R. Buchanan, P. Horsewood, and S.J. Brister Regulation of endothelial cell and platelet receptor-ligand binding by the 12- and 15-lipoxygenase monohydroxides, 12-, 15-HETE and 13-HODE Prostaglandins, Leukotrienes, and Essential Fatty Acids 58 1998 339 346
9. L. Buydens-Branchey, M. Branchey, and J.R. Hibbeln Associations between increases in plasma n-3 polyunsaturated fatty acids following supplementation and decreases in anger and anxiety in substance abusers Progress in Neuro-Psychopharmacology & Biological Psychiatry 32 2008 568 575
10. S. Chalon Omega-3 fatty acids and monoamine neurotransmission Prostaglandins, Leukotrienes, and Essential Fatty Acids 75 2006 259 269
11. C.H. Chen, W.J. Chen, and A.T. Cheng New approach to the validity of the alcohol use disorders identification test: stratum-specific likelihood ratios analysis Alcoholism: Clinical & Experimental Research 29 2005 602 608
12. C.C. Chiu, S.Y. Huang, K.P. Su, M.L. Lu, M.C. Huang, C.C. Chen, and W.W. Shen Polyunsaturated fatty acid deficit in patients with bipolar mania European Neuropsychopharmacology 13 2003 99 103
13. C.E. Coffey, G.S. Figiel, W.T. Djang, and R.D. Weiner Subcortical hyperintensity on magnetic resonance imaging: a comparison of normal and depressed elderly subjects The American Journal of Psychiatry 147 1990 187 189
14. S.M. Conklin, S.B. Manuck, J.K. Yao, J.D. Flory, J.R. Hibbeln, and M.F. Muldoon High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism Psychosomatic Medicine 69 2007 932 934
15. F.L. Crowe, C.M. Skeaff, T.J. Green, and A.R. Gray Serum phospholipid n 3 long-chain polyunsaturated fatty acids and physical and mental health in a population-based survey of New Zealand adolescents and adults American Journal of Clinical Nutrition 86 2007 1278 1285
16. A.Y. Dombrovski, B.H. Mulsant, P.R. Houck, S. Mazumdar, E.J. Lenze, C. Andreescu, J.M. Cyranowski, and C.F. Reynolds 3rd Residual symptoms and recurrence during maintenance treatment of late-life depression Journal of Affective Disorders 103 2007 77 82
17. R. Edwards, M. Peet, J. Shay, and D. Horrobin Depletion of docosahexaenoic acid in red blood cell membranes of depressive patients Biochemical Society Transactions 26 1998 S142
18. Y.Y. Fan, and R.S. Chapkin Importance of dietary gamma-linolenic acid in human health and nutrition Journal of Nutrition 128 1998 1411 1414
19. A.A. Farooqui, W.Y. Ong, and L.A. Horrocks Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders Pharmacological Reviews 58 2006 591 620
20. C. Féart, E. Peuchant, L. Letenneur, C. Samieri, D. Montagnier, A. Fourrier-Reglat, and P. Barberger-Gateau Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: data from the Bordeaux sample of the Three-City Study American Journal of Clinical Nutrition 87 2008 1156 1162
21. M.B. First, M. Gibbon, and R.L. Spitzer Structured Clinical Interview for DSM-IV Axis I Disorders SCID I: Clinical Version, Administration Booklet 1997 American Psychiatric Press Washington, DC
22. M.F. Folstein, S.E. Folstein, and P.R. McHugh Mini-mental state. A practical method for grading the cognitive state of patients for the clinician Journal of Psychiatric Research 12 1975 189 198
23. R.W. Friesen, and S.M. Innis Dietary arachidonic acid to EPA and DHA balance is increased among Canadian pregnant women with low fish intake Journal of Nutrition 139 2009 2344 2350
24. M. Fux, J. Benjamin, and B. Nemets A placebo-controlled cross-over trial of adjunctive EPA in OCD Journal of Psychiatric Research 38 2004 323 325
25. P. Green, H. Hermesh, A. Monselise, S. Marom, G. Presburger, and A. Weizman Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder European Neuropsychopharmacology 16 2006 107 113
26. P. Green, N. Anyakoha, G. Yadid, I. Gispan-Herman, and A. Nicolaou Arachidonic acid-containing phosphatidylcholine species are increased in selected brain regions of a depressive animal model: implications for pathophysiology Prostaglandins, Leukotrienes, and Essential Fatty Acids 80 2009 213 220
27. M. Hamilton A rating scale for depression Journal of Neurology, Neurosurgery, and Psychiatry 23 1960 56 62
28. M. Hamilton Development of a rating scale for primary depressive illness The British Journal of Social and Clinical Psychology 6 1967 278 296
29. W.S. Harris, W.C. Poston, and C.K. Haddock Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events Atherosclerosis 193 2007 1 10
30. J.R. Hibbeln, and N. Salem Jr. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy American Journal of Clinical Nutrition 62 1995 1 9
31. B. Kalyanaraman Nitrated lipids: a class of cell-signaling molecules Proceedings of the National Academy of Sciences of the United States of America 101 2004 11527 11528
32. M.B. Katan, J.P. Deslypere, A.P. van Birgelen, M. Penders, and M. Zegwaard Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study Journal of Lipid Research 38 1997 2012 2022
33. W.E. Lands Diets could prevent many diseases Lipids 38 2003 317 321
34. P.Y. Lin, and K.P. Su A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids The Journal of Clinical Psychiatry 68 2007 1056 1061
35. M. Maes, M. Maes, R. Smith, A. Christophe, P. Cosyns, R. Desnyder, and H. Meltzer Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids Journal of Affective Disorders 38 1996 35 46
36. M. Maes, A. Christophe, J. Delanghe, C. Altamura, H. Neels, and H.Y. Meltzer Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients Psychiatry Research 85 1999 275 291
37. P. Maruvada, and S. Srivastava Biomarkers for cancer diagnosis: implications for nutritional research Journal of Nutrition 134 2004 S1640 S1645
38. R.S. McIntyre, J.Z. Konarski, J.K. Soczynska, and S.H. Kennedy Residual anxiety symptoms in depressed primary care patients Journal of Psychiatric Practice 13 2007 125 128
39. R.K. McNamara, and S.E. Carlson Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology Prostaglandins, Leukotrienes, and Essential Fatty Acids 75 2006 329 349
40. R.K. McNamara, C.G. Hahn, R. Jandacek, T. Rider, P. Tso, K.E. Stanford, and N.M. Richtand Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder Biological Psychiatry 62 2007 17 24
41. J.C. Nelson, L. Portera, and A.C. Leon Residual symptoms in depressed patients after treatment with fluoxetine or reboxetine The Journal of Clinical Psychiatry 66 2005 1409 1414
42. M. Peet, and D.F. Horrobin A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs Archives of General Psychiatry 59 2002 913 919
43. M. Peet, B. Murphy, J. Shay, and D. Horrobin Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients Biological Psychiatry 43 1998 315 319
44. S.I. Rapoport, and F. Bosetti Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder? Archives of General Psychiatry 59 2002 592 596
45. A.J. Rush, H.C. Kraemer, H.A. Sackeim, M. Fava, M.H. Trivedi, E. Frank, P.T. Ninan, M.E. Thase, A.J. Gelenberg, D.J. Kupfer, D.A. Regier, J.F. Rosenbaum, O. Ray, A.F. Schatzberg, and ACNP Task Force Report by the ACNP Task Force on response and remission in major depressive disorder Neuropsychopharmacology 31 2006 1841 1853
46. A.P. Simopoulos The importance of the ratio of omega-6/omega-3 essential fatty acids Biomedicine and Pharmacotherapy 56 2002 365 379
47. C. Song, B.E. Leonard, and D.F. Horrobin Dietary ethyl-eicosapentaenoic acid but not soybean oil reverses central interleukin-1-induced changes in behavior, corticosterone and immune response in rats Stress 7 2004 43 54
48. D.C. Steffens, D.R. McQuoid, and K.R. Krishnan Partial response as a predictor of outcome in geriatric depression The American Journal of Geriatric Psychiatry 11 2003 340 348
49. R. Stewart, J.M. Kim, I.S. Shin, and J.S. Yoon Education and the association between vascular risk factors and cognitive function: a cross-sectional study in older Koreans with cognitive impairment International Psychogeriatrics 15 2003 27 36
50. K.P. Su, S.Y. Huang, C.C. Chiu, and W.W. Shen Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial European Neuropsychopharmacology 13 2003 267 271
51. A. Tanskanen, J.R. Hibbeln, J. Tuomilehto, A. Uutela, A. Haukkala, H. Viinamaki, J. Lehtonen, and E. Vartiainen Fish consumption and depressive symptoms in the general population in Finland Psychiatric Services 52 2001 529 531
52. M.E. Thase Update on partial response in depression The Journal of Clinical Psychiatry 70 Suppl. 6 2009 4 9
53. A.J. Thomas, R.N. Kalaria, and J.T. O'Brien Depression and vascular disease: what is the relationship? Journal of Affective Disorders 79 2004 81 95
54. H. Tiemeier, H.R. van Tuijl, A. Hofman, A.J. Kiliaan, and M.M. Breteler Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study American Journal of Clinical Nutrition 78 2003 40 46
55. C.H. Tseng, C.K. Chong, T.T. Chan, C.H. Bai, S.L. You, H.Y. Chiou, T.C. Su, and C.J. Chen Optimal anthropometric factor cutoffs for hyperglycemia, hypertension and dyslipidemia for the Taiwanese population Atherosclerosis 210 2010 585 589
56. M.N. Vercambre, M.C. Boutron-Ruault, K. Ritchie, F. Clavel-Chapelon, and C. Berr Long-term association of food and nutrient intakes with cognitive and functional decline: a 13-year follow-up study of elderly French women The British Journal of Nutrition 102 2009 419 427
57. M. Zimmerman, M.A. Posternak, and I. Chelminski Is the cutoff to define remission on the Hamilton Rating Scale for Depression too high? The Journal of Nervous and Mental Disease 193 2005 170 175
58. G.S. Zubenko, P. Sullivan, J.P. Nelson, S.H. Belle, F.J. Huff, and G.L. Wolf Brain imaging abnormalities in mental disorders of late life Archives of Neurology 47 1990 1107 1111